Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations

Eagle Pharmaceuticals, Inc. to acquire Acacia Pharma

Announced Jun 9, 2022 · Closed Jun 9, 2022 · Private target

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
Eagle Pharmaceuticals, Inc. (EGRX)
Target
Acacia Pharma
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Jun 9, 2022

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
William Blair
To the target
Not disclosed

Classification

Sector
Healthcare
Buyer's industry
Pharmaceutical Preparations
Sources
  • 8-K (EX-99.2) · Jun 9, 2022

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.